Julie Smith Exelixis, Inc. (EXEL) insider trading activity

Julie Smith is Director of EXELIXIS, INC.. Currently has a direct ownership of 10,778 shares of EXEL, which is worth approximately $417,000. The most recent transaction as insider was on Feb 28, 2025, when has been sold 19,294 shares (Common Stock) at a price of $37.62 per share, resulting in proceeds of $725,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.8K

0% 3M change

67.06% 12M change

Total Value Held $417,000

Julie Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	SELL Open market or private sale	$725,840 $37.62 p/Share	19,294 Reduced 64.16%	10,778 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	$381,442 $19.77 p/Share	19,294 Added 39.08%	30,072 Common Stock
Feb 27 2025	SELL Open market or private sale	$2,078,618 $38.13 p/Share	54,514 Reduced 83.49%	10,778 Common Stock
Feb 27 2025	BUY Exercise of conversion of derivative security	$1,097,911 $20.14 p/Share	54,514 Added 45.5%	65,292 Common Stock
Aug 13 2024	SELL Other acquisition or disposition	-	4,682 Reduced 30.28%	10,778 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	10,015 Added 39.31%	15,460 Common Stock
May 21 2024	SELL Open market or private sale	$576,153 $21.12 p/Share	27,280 Reduced 83.36%	5,445 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	16,424 Added 33.42%	32,725 Common Stock

Also insider at

STOK

Stoke Therapeutics, Inc. Healthcare

Julie Smith

Director

Alameda, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Value

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXELIXIS, INC.

Track Activities on EXEL

Account